Use of minicircle plasmids for gene therapy

Peter Mayrhofer1, Martin Schleef, Wolfgang Jechlinger

  • 1Mayrhofer & Jechlinger OEG, Vienna, Austria.

Insights

Minicircle DNA offers a safer and more effective nonviral gene therapy vector by removing bacterial DNA. This enhances transgene expression for improved cancer gene therapy and vaccination applications.

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Gene Therapy

Background:

  • Gene therapy aims to eliminate tumor cells by introducing genetic material.
  • Viral and nonviral vectors are used for gene transfer, each with pros and cons.
  • Minicircles are novel DNA vectors derived from plasmids for nonviral gene therapy.

Purpose of the Study:

  • To describe the production, purification, and application of minicircle DNA.
  • To discuss the rationale behind minicircle DNA's enhanced gene transfer efficiency.
  • To highlight minicircles as improved vectors for nonviral gene therapy and vaccination.

Main Methods:

  • Minicircle DNA is produced via site-specific recombination in Escherichia coli.
  • Purification methods isolate minicircle DNA from bacterial components.
  • Production and application protocols for minicircle DNA are detailed.

Main Results:

  • Minicircle DNA lacks bacterial backbone sequences, improving safety.
  • Minicircles demonstrate significantly enhanced transgene expression efficiency.
  • Studies show improved in vitro and in vivo gene transfer with minicircles compared to plasmids.

Conclusions:

  • Minicircle DNA represents a superior nonviral vector for gene therapy.
  • The absence of bacterial DNA enhances safety and transgene expression.
  • Minicircles hold significant promise for advancing cancer gene therapy and vaccination strategies.

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Conservative Site-specific Recombination and Phase Variation02:53

Conservative Site-specific Recombination and Phase Variation

Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...